HomeProductsBuilding BlocksHeterocyclic ScaffoldsIndolesMacimorelin
Chemical structure of CAS 381231-18-1

Macimorelin

CAS No.381231-18-1
MDL No.N/A
MFC26H30N6O3
MW474.60
InChI KeyUJVDJAPJQWZRFR-DHIUTWEWSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.381231-18-1
Product NameMacimorelin

Biological Targets

GHSR

Associated Conditions

Cachexia·pituitary dwarfism
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Adult growth hormone deficiency: current concepts.

Neurologia medico-chirurgica • Vol. 54, Issue 8 • 2014
PMID: 25070016PMC: PMC4533495DOI: 10.2176/nmc.ra.2014-0088

The macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis.

Expert review of molecular diagnostics • Vol. 14, Issue 6 • 2014
PMID: 24834478DOI: 10.1586/14737159.2014.915746

Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.

The Journal of clinical endocrinology and metabolism • Vol. 98, Issue 6 • 2013
PMID: 23559086PMC: PMC4207947DOI: 10.1210/jc.2013-1157

Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects.

The Journal of clinical endocrinology and metabolism • Vol. 92, Issue 5 • 2007
PMID: 17284637DOI: 10.1210/jc.2006-2160

Documentation

Similar Products